Instrumento Inactivo

Otros idiomas ValiRx Plc London S.E.

Acciones

Precio de cierre London S.E. Otros sitios de cotización
- ^GBX	-

24/04	Valirx plc reitera su previsión de beneficios para el año 2024	CI
22/04	Valirx plc anuncia cambios en su dirección	CI

Valirx plc Reiterates Earnings Guidance for the Year 2024	24/04
Valirx plc Announces Directorate Changes	22/04
ValiRx inks evaluation deal with Imperial College London for research	21/03
ValiRx plc Announces Signature of an Evaluation Agreement with Imperial College London	21/03
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat	19/03
ValiRx Kick off Search for New CEO	19/03
Valirx plc Announces Board Appointments, Subject to Completion of Regulatory Due Diligence	19/03
EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout	29/02
Valirx plc Intends to Appoint Martin Gouldstone as Non-Executive Director	29/02
ValiRx Says Shareholder Group's Requisition Notice Invalid	13/02
ValiRx says requisition notice from shareholder group is invalid	13/02
ValiRx signs research sharing deal with Dundee University	12/02
Valirx Signs Research, Evaluation Agreements with University of Dundee	12/02
ValiRx plc Announces Agreement with Dundee Uni and Project Initiation	12/02
ValiRx receives shareholder request for board change	09/02
ValiRx plc Announces Resignation of Stella Panu as A Non-Executive Director, Effective from 15 April 2024	18/01
ValiRx raises GBP192,200, part of wider GBP1.8 million raise	19/12
Good Energy says ZapMap expands into mainland Europe	13/12
ValiRx strikes deal with Ambrose Healthcare to license late-stage cancer treatment	06/12
ValiRx Signs Licensing Option Deal with Ambrose Healthcare	05/12

No hay resultados para esta búsqueda